Gap finder

Search review questions

Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.

Limit to evidence status or GRADE (optional)

611 questions in 50 reviews · Injuries

current versions
No studies 125 · 20.5%Ungraded 22 · 3.6%Very low 185 · 30.3%Low 171 · 28%Moderate 77 · 12.6%High 31 · 5.1%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

QuestionEffectEvidenceStatus / GRADE
Oral iron vs inactive control
Quality of life · patients with anaemia
Iron therapy in anaemic adults without chronic kidney disease (2014) · Cochrane
no estimate extracted1 study · 276 participantsVery low
Oral iron vs inactive control
Serious adverse events · patients with anaemia
Iron therapy in anaemic adults without chronic kidney disease (2014) · Cochrane
RR 0.96 [0.76, 1.22]5 studies · 731 participantsVery low
Parenteral iron vs inactive control
Mortality · patients with anaemia
Iron therapy in anaemic adults without chronic kidney disease (2014) · Cochrane
RR 1.04 [0.63, 1.69]10 studies · 2141 participantsVery low
Parenteral iron vs inactive control
Proportion requiring blood transfusion · patients with anaemia
Iron therapy in anaemic adults without chronic kidney disease (2014) · Cochrane
RR 0.84 [0.66, 1.06]8 studies · 1315 participantsVery low
Parenteral iron vs inactive control
Haemoglobin g/dL · patients with anaemia
Iron therapy in anaemic adults without chronic kidney disease (2014) · Cochrane
no estimate extracted9 studies · 1371 participantsVery low
Parenting interventions vs usual care
Medically attended or self‐reported injuries ‐ RCTs only · parents of children 18 years of age and younger
Parenting interventions for the prevention of unintentional injuries in childhood (2013) · Cochrane
RR 0.83 [0.73, 0.94]10 studies · 5074 participantsModerate
Continuous vs Intermittent Antibiotic Infusions
All‐cause mortality
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections (2013) · Cochrane
RR 0.89 [0.67, 1.2]19 studies · 1241 participantsModerate
Continuous vs Intermittent Antibiotic Infusions
Infection recurrence
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections (2013) · Cochrane
RR 1.22 [0.35, 4.19]8 studies · 398 participantsLow
Continuous vs Intermittent Antibiotic Infusions
Clinical cure
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections (2013) · Cochrane
RR 1.04 [0.95, 1.13]15 studies · 975 participantsLow
Continuous vs Intermittent Antibiotic Infusions
Super‐infection
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections (2013) · Cochrane
RR 1.08 [0.6, 1.94]12 studies · 813 participantsLow
Continuous vs Intermittent Antibiotic Infusions
Serious adverse events
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections (2013) · Cochrane
RR 1.36 [0.8, 2.3]10 studies · 871 participantsLow
Continuous vs Intermittent Antibiotic Infusions
Withdrawal due to adverse events
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections (2013) · Cochrane
RR 2.03 [0.52, 7.95]10 studies · 871 participantsLow
Continuous vs Intermittent Antibiotic Infusions
Adverse events
Continuous versus intermittent infusions of antibiotics for the treatment of severe acute infections (2013) · Cochrane
RR 1.02 [0.94, 1.12]5 studies · 575 participantsVery low
Respiratory muscle training vs control
Dyspnoea Borg scale, modified Borg scale, and visual analogue scale · cervical spinal cord injury
Respiratory muscle training for cervical spinal cord injury (2013) · Cochrane
no estimate extracted3 studies · 58 participantsLow
Respiratory muscle training vs control
Vital capacity · cervical spinal cord injury
Respiratory muscle training for cervical spinal cord injury (2013) · Cochrane
no estimate extracted4 studies · 108 participantsLow
Respiratory muscle training vs control
Maximum inspiratory pressure · cervical spinal cord injury
Respiratory muscle training for cervical spinal cord injury (2013) · Cochrane
no estimate extracted8 studies · 147 participantsLow
Respiratory muscle training vs control
Maximum expiratory pressure · cervical spinal cord injury
Respiratory muscle training for cervical spinal cord injury (2013) · Cochrane
no estimate extracted6 studies · 151 participantsLow
Respiratory muscle training vs control
Forced expiratory volume in 1 second · cervical spinal cord injury
Respiratory muscle training for cervical spinal cord injury (2013) · Cochrane
no estimate extracted4 studies · 97 participantsLow
Respiratory muscle training vs control
Quality of life · cervical spinal cord injury
Respiratory muscle training for cervical spinal cord injury (2013) · Cochrane
no estimate extracted4 studies · 78 participantsLow
Respiratory muscle training vs control
Respiratory complications · cervical spinal cord injury
Respiratory muscle training for cervical spinal cord injury (2013) · Cochrane
no estimate extracted1 study · 14 participantsHigh
Intervention NR
Spasticity Tallied Modified Ashworth Scale · patients with or at risk of contractures
Passive movements for the treatment and prevention of contractures (2013) · Cochrane
no estimate extracted121 participantsVery low
Intervention NR
Pain Pain Assessment Checklist for Seniors With Limited Ability to Communicate Scale from: 0 to 24 · patients with or at risk of contractures
Passive movements for the treatment and prevention of contractures (2013) · Cochrane
no estimate extracted101 participantsVery low
Intervention NR
Joint mobility Ankle dorsiflexion range of motion. Scale from 0 to 120 · patients with or at risk of contractures
Passive movements for the treatment and prevention of contractures (2013) · Cochrane
no estimate extracted40 participantsVery low
Intervention NR
Death at any time in trial period case mortality count · Patients with acute traumatic brain injury
Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury (2012) · Cochrane
RR 0.69 [0.54, 0.88]4 studies · 385 participantsModerate
Intervention NR
Favourable outcome GOS <9 or similar · Patients with acute traumatic brain injury
Hyperbaric oxygen therapy for the adjunctive treatment of traumatic brain injury (2012) · Cochrane
RR 1.94 [0.92, 4.08]4 studies · 380 participantsUngraded
Intervention NR
Death ( · any patients with conditions outside the marketing license for the intervention, particularly those at risk of…
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (2012) · Cochrane
RR 1.04 [0.55, 1.97]15 studies · 1219 participantsModerate
Intervention NR
Arterial thromboembolic events ( · any patients with conditions outside the marketing license for the intervention, particularly those at risk of…
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (2012) · Cochrane
RR 1.45 [1.02, 2.05]25 studies · 3849 participantsModerate
Intervention NR
Total operative and perioperative blood loss (mL) ( · any patients with conditions outside the marketing license for the intervention, particularly those at risk of…
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (2012) · Cochrane
no estimate extracted10 studies · 707 participantsLow
Intervention NR
Red cell transfusion requirements (mL) ( · any patients with conditions outside the marketing license for the intervention, particularly those at risk of…
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (2012) · Cochrane
no estimate extracted12 studies · 774 participantsLow
Intervention NR
Number of patients transfused ( · any patients with conditions outside the marketing license for the intervention, particularly those at risk of…
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (2012) · Cochrane
RR 0.85 [0.72, 1.01]8 studies · 868 participantsLow
Intervention NR
Total thromboembolic events ( · any patients with conditions outside the marketing license for the intervention, particularly those at risk of…
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (2012) · Cochrane
RR 1.35 [0.82, 2.25]13 studies · 1159 participantsModerate
Intervention NR
Death ( · any patients with conditions outside the marketing license for the intervention, particularly those at risk of…
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (2012) · Cochrane
RR 0.91 [0.78, 1.06]13 studies · 2856 participantsModerate
Intervention NR
Numbers of patients with reduced bleeding ( · any patients with conditions outside the marketing license for the intervention, particularly those at risk of…
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (2012) · Cochrane
RR 0.95 [0.88, 1.03]4 studies · 616 participantsLow
Intervention NR
Red cell transfusion requirements (mL) ( · any patients with conditions outside the marketing license for the intervention, particularly those at risk of…
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (2012) · Cochrane
no estimate extracted5 studies · 911 participantsLow
Intervention NR
Total thromboembolic events ( · any patients with conditions outside the marketing license for the intervention, particularly those at risk of…
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia (2012) · Cochrane
RR 1.14 [0.89, 1.47]13 studies · 2873 participantsModerate
Hyperbaric Oxygen (HBO) vs Normobaric Oxygen (NBO)
Presence of symptoms or signs at time of primary analysis (4‐6 weeks) · patients with carbon monoxide poisoning
Hyperbaric oxygen for carbon monoxide poisoning (2011) · Cochrane
OR 0.78 [0.54, 1.12]6 studies · 1361 participantsVery low
Oxime vs placebo
Deaths · patients with acute organophosphate pesticide poisoning
Oximes for acute organophosphate pesticide poisoning (2011) · Cochrane
OR 2.68 [0.93, 7.72]3 studies · 366 participantsVery low
Oxime vs placebo
Intermediate syndrome · patients with acute organophosphate pesticide poisoning
Oximes for acute organophosphate pesticide poisoning (2011) · Cochrane
OR 3.4 [1.62, 7.17]1 study · 110 participantsVery low
Oxime vs placebo
Ventilated · patients with acute organophosphate pesticide poisoning
Oximes for acute organophosphate pesticide poisoning (2011) · Cochrane
OR 2 [0.81, 4.95]3 studies · 366 participantsVery low
Higher dose vs lower dose
Deaths · patients with acute organophosphate pesticide poisoning
Oximes for acute organophosphate pesticide poisoning (2011) · Cochrane
OR 0.38 [0.1, 1.47]4 studies · 479 participantsVery low
Higher dose vs lower dose
Intermediate syndrome · patients with acute organophosphate pesticide poisoning
Oximes for acute organophosphate pesticide poisoning (2011) · Cochrane
OR 0.94 [0.24, 3.62]3 studies · 283 participantsVery low
Higher dose vs lower dose
Ventilated · patients with acute organophosphate pesticide poisoning
Oximes for acute organophosphate pesticide poisoning (2011) · Cochrane
OR 0.72 [0.08, 6.35]2 studies · 272 participantsVery low
Intervention NR
asteric* denotes studies reporting both speed and crash outcomes.
Speed cameras for the prevention of road traffic injuries and deaths (2010) · Cochrane
no estimate extractedNRNo studies
Intervention NR
A time halo effect lasted for 3 days following a single application of enforcement. With 5 days of consecutive enforcement a time halo of at least 6 days was noted. At the site of speed limit enforcement the average speed was reduced to around the...
Speed cameras for the prevention of road traffic injuries and deaths (2010) · Cochrane
no estimate extractedNRHigh
Intervention NR
2.8 km/h reduction in mean speed at monitoring site, 2km from experimental site.
Speed cameras for the prevention of road traffic injuries and deaths (2010) · Cochrane
no estimate extractedNRModerate
Intervention NR
Reductions in median speed by 40 km/h and 28km/h in left and middle car lanes and 23km/h in truck lane on autobahn, sustained through 10 years of continuous enforcement. Also reductions in 85th percentile speeds of 42 and 37km/h in car lanes and 3...
Speed cameras for the prevention of road traffic injuries and deaths (2010) · Cochrane
no estimate extractedNRLow
Intervention NR
During pilot program an overall 2.4 km/h reduction in mean speed with only small differences between the 3 cities. A 10.4% reduction in proportion of drivers exceeding the speed limit and a 4.5% reduction in those exceeding the speed limit by 10km.
Speed cameras for the prevention of road traffic injuries and deaths (2010) · Cochrane
no estimate extractedNRLow
Intervention NR
On 80 km/h sections an 8% reduction of speeding vehicles seen on experimental sites compared to control sites in year 1, with a further 2% decrease in year 2. On 100 km/h stretches a 5% reduction in number of speeders seen in year 1, with a furthe...
Speed cameras for the prevention of road traffic injuries and deaths (2010) · Cochrane
no estimate extractedNRLow
Intervention NR
Reduction in mean speeds by an average of 4.4 mph, 85% percentile speed reduction of 5.9 mph and a 35% reduction in percentage over the speed limit. These reductions were comparable for all monitored lengths e.g. up to 250m, 500m and 1 km.
Speed cameras for the prevention of road traffic injuries and deaths (2010) · Cochrane
no estimate extractedNRHigh
Intervention NR
65% reduction in speeding vehicles in excess of 15km/h or more, over the speed limit.
Speed cameras for the prevention of road traffic injuries and deaths (2010) · Cochrane
no estimate extractedNRLow